Literature DB >> 22178693

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Navneet S Majhail1, J Douglas Rizzo, Stephanie J Lee, Mahmoud Aljurf, Yoshiko Atsuta, Carmem Bonfim, Linda J Burns, Naeem Chaudhri, Stella Davies, Shinichiro Okamoto, Adriana Seber, Gerard Socie, Jeff Szer, Maria Teresa Van Lint, John R Wingard, Andre Tichelli.   

Abstract

Advances in hematopoietic cell transplantation (HCT) technology and supportive care techniques have led to improvements in long-term survival after HCT. Emerging indications for transplantation, introduction of newer graft sources (eg, umbilical cord blood) and transplantation of older patients using less intense conditioning regimens have also contributed to an increase in the number of HCT survivors. These survivors are at risk for developing late complications secondary to pre-, peri-, and posttransplantation exposures and risk factors. Guidelines for screening and preventive practices for HCT survivors were published in 2006. An international group of transplantation experts was convened in 2011 to review contemporary literature and update the recommendations while considering the changing practice of transplantation and international applicability of these guidelines. This review provides the updated recommendations for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic HCT. Copyright Â
© 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22178693      PMCID: PMC3279570          DOI: 10.1016/j.bbmt.2011.12.519

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  73 in total

Review 1.  Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.

Authors:  Oliver Grauer; Daniel Wolff; Hartmut Bertz; Hildegard Greinix; Jörn-Sven Kühl; Anita Lawitschka; Stephanie J Lee; Steven Z Pavletic; Ernst Holler; Ingo Kleiter
Journal:  Brain       Date:  2010-09-15       Impact factor: 13.501

2.  Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic cell transplantation.

Authors:  Sarah McAvoy; K Scott Baker; Daniel Mulrooney; Anne Blaes; Mukta Arora; Linda J Burns; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-17       Impact factor: 5.742

Review 3.  Hepatobiliary complications of hematopoietic cell transplantation, 40 years on.

Authors:  George B McDonald
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

4.  Vaccination of hematopoietic cell transplant recipients.

Authors:  P Ljungman; C Cordonnier; H Einsele; J Englund; C M Machado; J Storek; T Small
Journal:  Bone Marrow Transplant       Date:  2009-10       Impact factor: 5.483

5.  Regionally limited or rare infections: prevention after hematopoietic cell transplantation.

Authors:  J Gea-Banacloche; H Masur; C Arns da Cunha; C Arns da Cuhna; T Chiller; L V Kirchhoff; L Kirchoff; P Shaw; M Tomblyn; C Cordonnier
Journal:  Bone Marrow Transplant       Date:  2009-10       Impact factor: 5.483

Review 6.  Epidemiology of neglected tropical diseases in transplant recipients. Review of the literature and experience of a Brazilian HSCT center.

Authors:  Clarisse Martins Machado; Talita Chaves Martins; Iago Colturato; Marília Souza Leite; Anderson João Simione; Mair Pedro de Souza; Marcos Augusto Mauad; Vergílio Rensi Colturato
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2009 Oct-Dec       Impact factor: 1.846

Review 7.  Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management.

Authors:  Michelle L Griffith; Bipin N Savani; Jeffrey B Boord
Journal:  Blood       Date:  2010-05-03       Impact factor: 22.113

8.  Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase.

Authors:  John M Goldman; Navneet S Majhail; John P Klein; Zhiwei Wang; Kathleen A Sobocinski; Mukta Arora; Mary M Horowitz; J Douglas Rizzo
Journal:  J Clin Oncol       Date:  2010-03-08       Impact factor: 44.544

9.  Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.

Authors:  Paul J Martin; George W Counts; Frederick R Appelbaum; Stephanie J Lee; Jean E Sanders; H Joachim Deeg; Mary E D Flowers; Karen L Syrjala; John A Hansen; Rainer F Storb; Barry E Storer
Journal:  J Clin Oncol       Date:  2010-01-11       Impact factor: 44.544

10.  Cerebral angiitis in four patients with chronic GVHD.

Authors:  P Sostak; C S Padovan; S Eigenbrod; S Roeber; S Segerer; C Schankin; S Siegert; T Saam; D Theil; H-J Kolb; H Kretzschmar; A Straube
Journal:  Bone Marrow Transplant       Date:  2009-11-16       Impact factor: 5.483

View more
  108 in total

1.  Who Enrolls in an Online Cancer Survivorship Program? Reach of the INSPIRE Randomized Controlled Trial for Hematopoietic Cell Transplantation Survivors.

Authors:  Jean C Yi; Brie Sullivan; Wendy M Leisenring; Navneet S Majhail; Heather Jim; Alison Loren; Joseph Uberti; Victoria Whalen; Mary E D Flowers; Stephanie J Lee; Katie Maynard; Karen L Syrjala
Journal:  Biol Blood Marrow Transplant       Date:  2020-06-26       Impact factor: 5.742

2.  Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation.

Authors:  Kasey J Leger; K Scott Baker; Kara L Cushing-Haugen; Mary E D Flowers; Wendy M Leisenring; Paul J Martin; Jason A Mendoza; Kerryn W Reding; Karen L Syrjala; Stephanie J Lee; Eric J Chow
Journal:  Cancer       Date:  2018-01-09       Impact factor: 6.860

Review 3.  Osteoporosis after stem cell transplantation.

Authors:  Brian L McClune; Navneet S Majhail
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

Review 4.  Palliative care during and following allogeneic hematopoietic stem cell transplantation.

Authors:  Sandra A Mitchell
Journal:  Curr Opin Support Palliat Care       Date:  2018-03       Impact factor: 2.302

5.  Late cardiovascular complications after hematopoietic cell transplantation.

Authors:  Eric J Chow; Kenneth Wong; Stephanie J Lee; Kara L Cushing-Haugen; Mary E D Flowers; Debra L Friedman; Wendy M Leisenring; Paul J Martin; Beth A Mueller; K Scott Baker
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-22       Impact factor: 5.742

6.  Chronic GVHD and concurrent new-onset nephrotic syndrome in allogeneic transplant recipients. Incidence, pattern and therapeutic outcomes.

Authors:  B Dhakal; A Singavi; E P Cohen; M Dangal; J Palmer; A Dall; A D'Souza; M Hamadani; P N Hari
Journal:  Bone Marrow Transplant       Date:  2014-11-10       Impact factor: 5.483

Review 7.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

Authors:  Juan Gea-Banacloche; Krishna V Komanduri; Paul Carpenter; Sophie Paczesny; Stefanie Sarantopoulos; Jo-Anne Young; Nahed El Kassar; Robert Q Le; Kirk R Schultz; Linda M Griffith; Bipin N Savani; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-14       Impact factor: 5.742

Review 8.  Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.

Authors:  Yoshihiro Inamoto; Nuria Valdés-Sanz; Yoko Ogawa; Monica Alves; Luigi Berchicci; John Galvin; Hildegard Greinix; Gregory A Hale; Biljana Horn; Debra Kelly; Hien Liu; Scott Rowley; Helene Schoemans; Ami Shah; Maria Teresa Lupo Stanghellini; Vaibhav Agrawal; Ibrahim Ahmed; Asim Ali; Neel Bhatt; Michael Byrne; Saurabh Chhabra; Zachariah DeFilipp; Kristina Fahnehjelm; Nosha Farhadfar; Erich Horn; Catherine Lee; Sunita Nathan; Olaf Penack; Pinki Prasad; Seth Rotz; Alicia Rovó; Jean Yared; Steven Pavletic; Grzegorz W Basak; Minoo Battiwalla; Rafael Duarte; Bipin N Savani; Mary E D Flowers; Bronwen E Shaw; Igor Petriček
Journal:  Biol Blood Marrow Transplant       Date:  2018-11-24       Impact factor: 5.742

9.  Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study.

Authors:  Can-Lan Sun; John H Kersey; Liton Francisco; Saro H Armenian; K Scott Baker; Daniel J Weisdorf; Stephen J Forman; Smita Bhatia
Journal:  Biol Blood Marrow Transplant       Date:  2013-04-10       Impact factor: 5.742

10.  Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation.

Authors:  Areej R El-Jawahri; Harry B Vandusen; Lara N Traeger; Joel N Fishbein; Tanya Keenan; Emily R Gallagher; Joseph A Greer; William F Pirl; Vicki A Jackson; Thomas R Spitzer; Yi-Bin A Chen; Jennifer S Temel
Journal:  Cancer       Date:  2015-12-09       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.